Lara A Householder1, Ross Comisford2, Silvana Duran-Ortiz3, Kevin Lee4, Katie Troike1, Cody Wilson2, Adam Jara5, Mitchell Harberson4, Edward O List5, John J Kopchick6, Darlene E Berryman7. 1. The Diabetes Institute, Ohio University, Athens, OH, United States; Edison Biotechnology Institute, Ohio University, Athens, OH, United States; School of Applied Health Sciences and Wellness, College of Health Sciences and Professions, United States. 2. The Diabetes Institute, Ohio University, Athens, OH, United States; Edison Biotechnology Institute, Ohio University, Athens, OH, United States. 3. Edison Biotechnology Institute, Ohio University, Athens, OH, United States; School of Applied Health Sciences and Wellness, College of Health Sciences and Professions, United States. 4. The Diabetes Institute, Ohio University, Athens, OH, United States; Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, United States. 5. Edison Biotechnology Institute, Ohio University, Athens, OH, United States. 6. The Diabetes Institute, Ohio University, Athens, OH, United States; Edison Biotechnology Institute, Ohio University, Athens, OH, United States; Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, United States. 7. The Diabetes Institute, Ohio University, Athens, OH, United States; Edison Biotechnology Institute, Ohio University, Athens, OH, United States; Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, United States. Electronic address: berrymad@ohio.edu.
Abstract
OBJECTIVE: White adipose tissue (WAT) fibrosis - the buildup of extracellular matrix (ECM) proteins, primarily collagen - is now a recognized hallmark of tissue dysfunction and is increased with obesity and lipodystrophy. While growth hormone (GH) is known to increase collagen in several tissues, no previous research has addressed its effect on ECM in WAT. Thus, the purpose of this study is to determine if GH influences WAT fibrosis. DESIGN: This study examined WAT from four distinct strains of GH-altered mice (bGH and GHA transgenic mice as well as two tissue specific GH receptor gene disrupted lines, fat growth hormone receptor knockout or FaGHRKO and liver growth hormone receptor knockout or LiGHRKO mice). Collagen content and adipocyte size were studied in all cohorts and compared to littermate controls. In addition, mRNA expression of fibrosis-associated genes was assessed in one cohort (6month old male bovine GH transgenic and WT mice) and cultured 3T3-L1 adipocytes treated with GH. RESULTS: Collagen stained area was increased in WAT from bGH mice, was depot-dependent, and increased with age. Furthermore, increased collagen content was associated with decreased adipocyte size in all depots but more dramatic changes in the subcutaneous fat pad. Notably, the increase in collagen was not associated with an increase in collagen gene expression or other genes known to promote fibrosis in WAT, but collagen gene expression was increased with acute GH administration in 3T3-LI cells. In contrast, evaluation of 6month old GH antagonist (GHA) male mice showed significantly decreased collagen in the subcutaneous depot. Lastly, to assess if GH induced collagen deposition directly or indirectly (via IGF-1), fat (Fa) and liver (Li) specific GHRKO mice were evaluated. Decreased fibrosis in FaGHRKO and increased fibrosis in LiGHRKO mice suggest GH is primarily responsible for the alterations in collagen. CONCLUSIONS: Our results show that GH action is positively associated with an increase in WAT collagen content as well as a decrease in adipocyte size, particularly in the subcutaneous depot. This effect appears to be due to GH and not IGF-1 and reveals a novel means by which GH regulates WAT accumulation.
OBJECTIVE: White adipose tissue (WAT) fibrosis - the buildup of extracellular matrix (ECM) proteins, primarily collagen - is now a recognized hallmark of tissue dysfunction and is increased with obesity and lipodystrophy. While growth hormone (GH) is known to increase collagen in several tissues, no previous research has addressed its effect on ECM in WAT. Thus, the purpose of this study is to determine if GH influences WAT fibrosis. DESIGN: This study examined WAT from four distinct strains of GH-altered mice (bGH and GHAtransgenic mice as well as two tissue specific GH receptor gene disrupted lines, fatgrowth hormone receptor knockout or FaGHRKO and liver growth hormone receptor knockout or LiGHRKO mice). Collagen content and adipocyte size were studied in all cohorts and compared to littermate controls. In addition, mRNA expression of fibrosis-associated genes was assessed in one cohort (6month old male bovineGHtransgenic and WT mice) and cultured 3T3-L1 adipocytes treated with GH. RESULTS: Collagen stained area was increased in WAT from bGH mice, was depot-dependent, and increased with age. Furthermore, increased collagen content was associated with decreased adipocyte size in all depots but more dramatic changes in the subcutaneous fat pad. Notably, the increase in collagen was not associated with an increase in collagen gene expression or other genes known to promote fibrosis in WAT, but collagen gene expression was increased with acute GH administration in 3T3-LI cells. In contrast, evaluation of 6month old GH antagonist (GHA) male mice showed significantly decreased collagen in the subcutaneous depot. Lastly, to assess if GH induced collagen deposition directly or indirectly (via IGF-1), fat (Fa) and liver (Li) specific GHRKO mice were evaluated. Decreased fibrosis in FaGHRKO and increased fibrosis in LiGHRKO mice suggest GH is primarily responsible for the alterations in collagen. CONCLUSIONS: Our results show that GH action is positively associated with an increase in WAT collagen content as well as a decrease in adipocyte size, particularly in the subcutaneous depot. This effect appears to be due to GH and not IGF-1 and reveals a novel means by which GH regulates WAT accumulation.
Authors: Nadia Alkhouli; Jessica Mansfield; Ellen Green; James Bell; Beatrice Knight; Neil Liversedge; Ji Chung Tham; Richard Welbourn; Angela C Shore; Katarina Kos; C Peter Winlove Journal: Am J Physiol Endocrinol Metab Date: 2013-10-08 Impact factor: 4.310
Authors: Jens O L Jørgensen; Louise Møller; Morten Krag; Nils Billestrup; Jens S Christiansen Journal: Endocrinol Metab Clin North Am Date: 2007-03 Impact factor: 4.741
Authors: Darlene E Berryman; Edward O List; Lucila Sackmann-Sala; Ellen Lubbers; Rachel Munn; John J Kopchick Journal: Growth Horm IGF Res Date: 2011-04-05 Impact factor: 2.372
Authors: Adam Jara; Chance M Benner; Don Sim; Xingbo Liu; Edward O List; Lara A Householder; Darlene E Berryman; John J Kopchick Journal: Endocrinology Date: 2013-01-01 Impact factor: 4.736
Authors: Darlene E Berryman; Ellen R Lubbers; Vishakha Magon; Edward O List; John J Kopchick Journal: J Gerontol A Biol Sci Med Sci Date: 2013-05-21 Impact factor: 6.053
Authors: Jonathan A Young; Brooke E Henry; Fabian Benencia; Stephen Bell; Edward O List; John J Kopchick; Darlene E Berryman Journal: J Neuroendocrinol Date: 2020-04-29 Impact factor: 3.627
Authors: Elizabeth A Jensen; Jonathan A Young; Zachary Jackson; Joshua Busken; Edward O List; Ronan K Carroll; John J Kopchick; Erin R Murphy; Darlene E Berryman Journal: Endocrinology Date: 2020-04-01 Impact factor: 4.736
Authors: Edward O List; Darlene E Berryman; Mathew Buchman; Caitlin Parker; Kevin Funk; Stephen Bell; Silvana Duran-Ortiz; Yanrong Qian; Jonathan A Young; Cody Wilson; Julie Slyby; Savannah McKenna; Elizabeth A Jensen; John J Kopchick Journal: Endocrinology Date: 2019-01-01 Impact factor: 4.736
Authors: Edward O List; Darlene E Berryman; Mathew Buchman; Elizabeth A Jensen; Kevin Funk; Silvana Duran-Ortiz; Yanrong Qian; Jonathan A Young; Julie Slyby; Savannah McKenna; John J Kopchick Journal: Endocrinology Date: 2019-07-01 Impact factor: 4.736
Authors: Elizabeth A Jensen; Jonathan A Young; Zachary Jackson; Joshua Busken; Jaycie Kuhn; Maria Onusko; Ronan K Carroll; Edward O List; J Mark Brown; John J Kopchick; Erin R Murphy; Darlene E Berryman Journal: Endocrinology Date: 2022-07-01 Impact factor: 5.051
Authors: Silvana Duran-Ortiz; Jonathan A Young; Adam Jara; Elizabeth A Jensen; Reetobrata Basu; Edward O List; Yanrong Qian; John J Kopchick; Darlene E Berryman Journal: J Neuroendocrinol Date: 2020-10-12 Impact factor: 3.627
Authors: Darlene E Berryman; Edward O List; Jonathan A Young; Mat Buchman; Silvana Duran-Ortiz; Colin Kruse; Stephen Bell; John J Kopchick Journal: Pituitary Date: 2021-01-12 Impact factor: 3.599
Authors: Elizabeth A Jensen; Jonathan A Young; Jaycie Kuhn; Maria Onusko; Joshua Busken; Edward O List; John J Kopchick; Darlene E Berryman Journal: Pituitary Date: 2021-08-09 Impact factor: 4.107